Net income
−$3.5M
+10.5% vs same quarter last year
EPS, diluted
−$0.18
+47.1% vs same quarter last year
Operating cash flow
−$2.5M
+38.2% vs same quarter last year
Operating income
−$3.6M
+11.2% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $2.8M | $9.2M |
| FY24 | $226K | −$166.5M |
| FY23 | $226K | −$18.9M |
| FY22 | $226K | −$19M |
| FY21 | $226K | −$16.2M |
| FY20 | $231K | −$25.2M |
| FY19 | $2.2M | −$21.5M |
| FY18 | $1.2M | −$20.6M |
| FY17 | $787K | −$24.1M |
| FY16 | $5.5M | −$19.7M |
| FY15 | $11.5M | −$24M |
| FY14 | $800K | −$63.7M |
| FY13 | $4.8M | −$62.5M |
| FY12 | $46.2M | −$29.9M |
| FY11 | $1.5M | −$26.3M |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | −640.7% | 328.7% |
| FY24 | −62997.3% | −73682.7% |
| FY23 | −8981.4% | −8384.1% |
| FY22 | −8684.5% | −8391.2% |
| FY21 | −7299.1% | −7151.8% |
| FY20 | −10819.5% | −10890.5% |
| FY19 | −994% | −985% |
| FY18 | −1895.9% | −1675.3% |
| FY17 | −3270.3% | −3061.2% |
| FY16 | −427.4% | −354.6% |
| FY15 | −209.3% | −209.3% |
| FY14 | −7968% | −7960.2% |
| FY13 | −1309.1% | −1315.9% |
| FY12 | −48.2% | −64.8% |
| FY11 | −1854.3% | −1768.3% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$20.8M |
| FY24 | −$33.4M |
| FY23 | −$17.9M |
| FY22 | - |
| FY21 | - |
| FY20 | −$23.1M |
| FY19 | −$20.9M |
| FY18 | - |
| FY17 | - |
| FY16 | - |
| FY15 | - |
| FY14 | −$57.9M |
| FY13 | −$62M |
| FY12 | $1.4M |
| FY11 | −$14.4M |
- Traws Pharma
- Healthcare median
Show the numbers
| Year | Traws Pharma | Healthcare median |
|---|---|---|
| FY25 | 328.7% | −30.6% |
| FY24 | −73682.7% | −47% |
| FY23 | −8384.1% | −58% |
| FY22 | −8391.2% | −80.4% |
| FY21 | −7151.8% | −71.9% |
| FY20 | −10890.5% | −62.2% |
| FY19 | −985% | −46.3% |
| FY18 | −1675.3% | −49.6% |
| FY17 | −3061.2% | −45.9% |
| FY16 | −354.6% | −36% |
| FY15 | −209.3% | −38.4% |
| FY14 | −7960.2% | −35.5% |
| FY13 | −1315.9% | −37.1% |
| FY12 | −64.8% | −29.1% |
| FY11 | −1768.3% | −27.9% |